Genetic Study for Inflammatory Bowel Disease
(MAAIS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify the genes responsible for Inflammatory Bowel Disease (IBD) in African Americans. The research focuses on individuals with or without conditions like Crohn's disease or ulcerative colitis, both types of IBD. Participants will provide health information and a blood sample, which can be collected at a convenient location. The study seeks African Americans with a confirmed IBD diagnosis or without any IBD and no family history of it for comparison. As an unphased study, this research offers participants the chance to contribute to groundbreaking genetic discoveries in IBD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on collecting health information and a blood sample.
Why are researchers excited about this trial?
The Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS) is not testing a new treatment but is instead focused on understanding how inflammatory bowel disease (IBD) affects African-American individuals differently. Researchers are excited about this trial because it aims to uncover unique genetic, environmental, or lifestyle factors that might contribute to IBD in this population. This could lead to more personalized and effective treatment options in the future, tailored specifically for African-Americans. By identifying these distinctive factors, the study has the potential to improve diagnosis, management, and outcomes for African-American patients with IBD, who are often underrepresented in clinical research.
Who Is on the Research Team?
Mark Lazarev, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Participants provide health information and a blood sample for genetic analysis
Follow-up
Participants' data is analyzed for genetic and environmental factors contributing to IBD
What Are the Treatments Tested in This Trial?
Interventions
- N/A
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
University of Alabama at Birmingham
Collaborator
University of Louisville
Collaborator
University of Maryland, Baltimore
Collaborator
University of North Carolina, Chapel Hill
Collaborator
Meharry Medical College
Collaborator
Weill Medical College of Cornell University
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Baylor College of Medicine
Collaborator